The associations between common neuroimaging parameters of Progressive Supranuclear Palsy in magnetic resonance imaging and non-specific inflammatory factors - pilot study

Front Immunol. 2024 Aug 8:15:1458713. doi: 10.3389/fimmu.2024.1458713. eCollection 2024.

Abstract

Progressive Supranuclear Palsy is an atypical parkinsonism based on tauopathic pathology. Growing interest is associated with the pathomechanism of this disease. Among theories analyzing this issue can be mentioned the one highlighting the significance of inflammation. In this study authors examined 14 patients with PSP-Richardson syndrome (PSP-RS) and 13 healthy volunteers using laboratory testing based on the analysis of interleukins 1 and 6 (IL-1 and IL-6), tau in the cerebrospinal fluid (CSF) and non-specific parameters of peripheral inflammation in the serum (IL-1, IL-6, neutrophils, lymphocytes, monocytes, platelets and the ratios based on the factors). All of the patients underwent neuroimaging using magnetic resonance imaging using 3 Tesla. The serum levels of IL-1 were positively correlated with the area of the mesencephalon, suggesting that higher levels of IL-1 are not linked with atrophic changes in this region, whereas serum levels IL-6 was positively correlated with frontal horn width and negatively correlated with superior cerebellar area. Additionally IL-6 in the serum was found to be correlated with neutrophil-to-high density lipoprotein ratio. The observations were not confirmed in the analysis of the levels of interleukins in the CSF. To the best of our knowledge this work is one of the first analyzing this issue. The outcome of the work shows that the role of interleukins associated with microglial activation may possibly differ in the context of neurodegenerative changes, moreover the role of peripheral inflammation in PSP requires further analysis.

Keywords: PSP; atypical parkinsonisms; neurodegeneration; neuroinflammation; tauopathy.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Female
  • Humans
  • Inflammation / diagnostic imaging
  • Interleukin-1 / blood
  • Interleukin-6 / blood
  • Interleukin-6 / cerebrospinal fluid
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Neuroimaging / methods
  • Pilot Projects
  • Supranuclear Palsy, Progressive* / blood
  • Supranuclear Palsy, Progressive* / cerebrospinal fluid
  • Supranuclear Palsy, Progressive* / diagnostic imaging
  • tau Proteins / blood
  • tau Proteins / cerebrospinal fluid

Substances

  • tau Proteins
  • Biomarkers
  • Interleukin-6
  • Interleukin-1

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The project was funded by an internal grant nr MB/M/09 (16).